|
|
|
Insider
Information: |
Kayyem Jon Faiz |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
375,074 |
|
Indirect Shares
|
10,693,978 |
|
|
Direct
Value |
$4,750,833 |
|
|
Indirect Value
|
$17,161,998 |
|
|
Total
Shares |
11,069,052 |
|
|
Total
Value |
$21,912,830 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Aeolus Pharmaceuticals Inc |
AOLS |
10% Owner |
|
0 |
2006-06-05 |
9,800,000 |
Premium* |
|
Genmark Diagnostics, Inc. |
GNMK |
SVP, Research & Develo... |
2018-02-02 |
197,622 |
2018-02-02 |
713,893 |
Premium* |
|
Inhibrx, Inc. |
INBX |
Director |
2022-08-02 |
0 |
2024-05-30 |
0 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2023-08-03 |
177,452 |
2023-08-03 |
180,085 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
169 |
103,888 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-02-03 |
4 |
S |
$4.99 |
$9,561 |
D/D |
(1,916) |
101,894 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
53,287 |
155,181 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-03-01 |
4 |
S |
$4.93 |
$6,828 |
D/D |
(1,385) |
153,796 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-03-02 |
4 |
S |
$4.87 |
$765 |
D/D |
(157) |
153,639 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-03-07 |
4 |
S |
$5.76 |
$2,097 |
D/D |
(364) |
153,275 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-05-02 |
4 |
S |
$5.79 |
$782 |
D/D |
(135) |
153,140 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-06-03 |
4 |
S |
$8.53 |
$1,066 |
D/D |
(125) |
153,015 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-06-07 |
4 |
S |
$8.98 |
$2,784 |
D/D |
(310) |
152,705 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-08-02 |
4 |
S |
$9.88 |
$1,334 |
D/D |
(135) |
152,570 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-09-02 |
4 |
S |
$8.62 |
$1,146 |
D/D |
(133) |
152,437 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-09-07 |
4 |
S |
$8.69 |
$2,694 |
D/D |
(310) |
152,127 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-11-02 |
4 |
S |
$10.30 |
$1,391 |
D/D |
(135) |
151,992 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-12-02 |
4 |
S |
$11.30 |
$1,492 |
D/D |
(132) |
151,860 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2016-12-07 |
4 |
S |
$11.08 |
$3,468 |
D/D |
(313) |
151,547 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2017-01-19 |
4 |
S |
$12.47 |
$71,303 |
D/D |
(5,718) |
159,460 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2017-01-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,631 |
165,178 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2017-02-02 |
4 |
S |
$11.58 |
$1,517 |
D/D |
(131) |
159,329 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2017-02-21 |
4 |
S |
$10.08 |
$52,920 |
D/D |
(5,250) |
154,079 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2017-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
48,750 |
202,829 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2017-03-03 |
4 |
S |
$12.29 |
$1,610 |
D/D |
(131) |
202,698 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2017-03-07 |
4 |
S |
$12.18 |
$3,788 |
D/D |
(311) |
202,387 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2017-05-02 |
4 |
S |
$13.34 |
$1,774 |
D/D |
(133) |
202,254 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2017-05-19 |
4 |
S |
$12.89 |
$16,306 |
D/D |
(1,265) |
200,989 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
SVP, Research & Development |
|
2017-06-02 |
4 |
S |
$12.89 |
$1,701 |
D/D |
(132) |
200,857 |
0 |
- |
|
91 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|